NCT04450095View on ClinicalTrials.gov

Effects of Endothelin Receptor Antagonist on Ischemic Kidney Injury During Nephron Sparing Surgery

PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 11, 2018

Primary Completion Date

February 1, 2020

Study Completion Date

October 1, 2020

Conditions
Kidney Failure, Acute
Interventions
DRUG

Ambrisentan 10 MG

be given once a day for 5 days, starting 48 hours before surgery

Trial Locations (2)

3339419

Bnai-Zion Medical Center, Haifa

3525408

Department of Physiology, The Bruce and Ruth Rapapport Faculty of Medicine, Technion, Haifa

Sponsors
All Listed Sponsors
collaborator

Rambam Health Care Campus

OTHER

lead

Bnai Zion Medical Center

OTHER_GOV